FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileNanosonics Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
NAN.AX
Nanosonics Limited Stock AnalysisComprehensive stock analysis for Nanosonics Limited (NAN.AX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisNAN.AX
NAN.AX
Nanosonics Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
NAN.AX
  1. Home
  2. Stocks
  3. Nanosonics Limited

Nanosonics Limited

🇦🇺NAN.AX•ASX

Nanosonics Limited

🇦🇺NAN.AX•ASX
P/E ratio
50.25

Your view on NAN.AX

P/E
50.25
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Nanosonics Limited

Industry
Medical - Instruments & Supplies
Sector
Healthcare
CEO
Michael C. Kavanagh
Headquarters
Building A, Macquarie Park, NSW, AU
Industry
Medical - Instruments & Supplies
Sector
Healthcare
CEO
Michael C. Kavanagh
Headquarters
Building A, Macquarie Park, NSW, AU
Description

Nanosonics Limited, along with its subsidiaries, functions as a global infection prevention enterprise with operations in Australia and beyond. The company focuses on the production and distribution of its trophon ultrasound probe disinfection system, including all related supplies and accessories.

Additionally, it dedicates resources to the exploration, development, and market launch of innovative infection control, decontamination products, and their associated technologies.

Key offerings from Nanosonics include trophon2, an advanced device for high-level disinfection of ultrasound probes; trophon EPR, a low-temperature, high-level disinfection method specifically for intra-cavity ultrasound probes; and Nanosonics AuditPro, a comprehensive solution for managing compliance with infection control workflows.

Established in 2000, Nanosonics Limited is headquartered in Macquarie Park, Australia.

Financial Data

Stock Data

Price chart, volume, and trading data.

FRC Fair Value Algorithm

What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.

About this section

Fair value for Nanosonics Limited from FRC's valuation model, read against the market price. NAN.AX last traded at AUD 3.57, 50.3× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Nanosonics Limited. Starting points for Nanosonics Limited: P/E 50.3, EPS AUD 0.06, beta 1.22 — an Medical - Instruments & Supplies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Nanosonics Limited. Nanosonics Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Nanosonics Limited. Trailing twelve-month EPS for Nanosonics Limited stands at AUD 0.06. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Wall Street analysts· not FRC research
Nov 20, 2026
More →

Earnings per share estimates

Per shareThis quarterSep 2025Next quarterDec 2025This yearYear to Jun 2027Next yearYear to Jun 2028
Average estimateAUD 0.00AUD 0.03AUD 0.03AUD 0.05
Lowest estimateAUD 0.00AUD 0.03AUD 0.02AUD 0.02
Highest estimateAUD 0.00AUD 0.03AUD 0.04AUD 0.07
Number of analysts0155
A year ago−AUD 0.001AUD 0.03AUD 0.06—
Growth vs a year ago—+1.2%−42.9%—

1The year-ago figure includes one-time items, so growth is not shown.

Revenue estimates

TotalThis quarterSep 2025Next quarterDec 2025This yearYear to Jun 2027Next yearYear to Jun 2028
Average estimateAUD 109.58MAUD 104.59MAUD 219.05MAUD 239.00M
Lowest estimateAUD 109.58MAUD 104.59MAUD 214.39MAUD 223.71M
Highest estimateAUD 109.58MAUD 104.59MAUD 223.39MAUD 250.61M
Number of analysts6177
A year agoAUD 60.39MAUD 85.72MAUD 203.47M—
Growth vs a year ago+81.5%+22.0%+7.7%—

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Nanosonics Limited. Nanosonics Limited has reported as a listed company since 2007. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold NAN.AX15 companies · 8 funds
Compare NAN.AX with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustry
AHC.AXAustco Healthcare LimitedHealthcareMedical - Instruments & Supplies—
ANN.AXAnsell LimitedHealthcareMedical - Instruments & Supplies—
TRJ.AXTrajan Group Holdings LimitedHealthcareMedical - Instruments & Supplies—
More Medical - Instruments & Supplies companies
TickerTypeCompanySectorExchangeMkt cap
SSSGYSartorius AGHealthcareOTC$15.8B
STAASTAAR Surgical CompanyHealthcareNASDAQ$1.3B
STSSSharps Technology, Inc.HealthcareNASDAQ$53.7M
STVNStevanato Group S.p.A.HealthcareNYSE$4.2B
STXSStereotaxis, Inc.HealthcareAMEX$94.8M
SUVPFSartorius AGHealthcareOTC$18.7B
SVSOSheerVision, Inc.HealthcareOTC$2,551
TCGGYTecan Group AGHealthcareOTC$2.3B
TCHBFTecan Group AGHealthcareOTC$2.2B
TDVXFTobii Dynavox AB (publ)HealthcareOTC$981.6M
TFXTeleflex IncorporatedHealthcareNYSE$6.6B
TGLVYTop Glove Corporation Bhd.HealthcareOTC$1.1B
ETFs holding Nanosonics Limited
TickerFundFund assets% of the fund
VXUSVanguard Total International Stock ETF$163.2B in assets0.00%
VEAVanguard FTSE Developed Markets ETF$231.6B in assets0.00%
IEFAiShares Core MSCI EAFE ETF$188.8B in assets0.00%
VSSVanguard FTSE All-World ex-US Small-Cap ETF$11.6B in assets0.01%
GWXState Street SPDR S&P International Small Cap ETF$882M in assets0.05%
AVDSAvantis International Small Cap Equity ETF$379M in assets0.02%
DFISDimensional - International Small Cap ETF$5.8B in assets0.01%
IPACiShares Core MSCI Pacific ETF$2.6B in assets0.01%

Largest holders first, then the funds most concentrated in NAN.AX.

Open Comparable Analysis
Ownership & News

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Nanosonics Limited. Coverage tracks Nanosonics Limited within Medical - Instruments & Supplies (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Nanosonics Limited.

NAN.AX AnalysisFair
Past
1
Growth
4
Health
5
Profit
2
Value
1